+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosupplements Containing Antibiotics Market - Global Forecast to 2030- Product Image
Biosupplements Containing Antibiotics Market - Global Forecast to 2030- Product Image
New

Biosupplements Containing Antibiotics Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081238
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The past decade has seen a notable convergence between traditional biosupplement formulations and targeted antibiotic compounds. Biosupplements containing antibiotics integrate microbial growth inhibitors with vitamins, minerals, and botanical extracts to support health outcomes ranging from digestive balance to immune resilience. This hybrid category emerged in response to rising antibiotic resistance patterns, shifting consumer preference toward preventative wellness, and evolving regulatory frameworks that permit low-dose antibiotic inclusion for specific therapeutic objectives. Manufacturers now harness antibiotics not only to disrupt pathogenic populations but also to foster a balanced microbiome, addressing gut dysbiosis, inflammatory skin conditions, and compromised immune defenses.

Consumer adoption reflects heightened health literacy, as individuals seek products backed by scientific validation and clinical data. The interplay between natural extracts like Echinacea or probiotic strains and antibiotic actives underscores a broader industry drive toward synergistic blends. Collaborative efforts among pharmaceutical firms, nutraceutical developers, and academic researchers fuel innovation, generating pipelines of novel formulations. Advanced research in microbial genomics and delivery technologies enables targeted action with minimal systemic exposure. Looking ahead, companies must navigate dynamic regulatory environments, emerging formulation innovations, and evolving consumer expectations to fully capitalize on this transformative segment.

Transformative Shifts Redefining Product Innovation and Regulation

Transformative shifts in this sector arise from advances in formulation science, heightened regulatory scrutiny, and changing consumer values. Recent investments in microencapsulation, liposomal delivery, and time-release matrices have enhanced antibiotic bioavailability while mitigating gastrointestinal discomfort. At the same time, chemical-free preservative systems and herbal stabilizers offer safer alternatives to synthetic additives, satisfying growing demand for clean-label solutions. Regulatory bodies have responded with updated guidance on permissible antibiotic levels, improved labeling requirements, and post-market surveillance measures, compelling manufacturers to adopt comprehensive compliance frameworks.

Consumer priorities have pivoted toward personalized wellness, driving segmentation by microbiome profiles, genetic predispositions, and lifestyle factors. Digital health platforms now facilitate at-home microbiome testing, empowering tailored product recommendations. Simultaneously, concerns about antibiotic resistance have encouraged the development of narrow-spectrum and graded-release formulations that minimize collateral impact on beneficial bacterial communities. Moreover, the shift toward online retail and subscription services accelerates product adoption, while eco-conscious packaging and carbon-neutral manufacturing strategies resonate with environmentally aware consumers. Together, these converging trends reshape product pipelines, investment strategies, and go-to-market approaches.

Assessing the Cumulative Impact of 2025 US Tariffs on Supply Chains

Tariff adjustments implemented in 2025 have exerted a cumulative effect on the biosupplements with antibiotic category, impacting raw material sourcing, production costs, and retail pricing. Increased duties on antibiotic precursors imported from key supply hubs have raised ingredient expenses, compelling manufacturers to reassess supplier networks and negotiate volume discounts. These cost pressures have cascaded through the value chain, prompting operational optimizations such as nearshoring of intermediate processing, investment in local fermentation capacity, and strategic stockpiling of critical inputs.

Retailers and distributors have encountered margin contractions, leading to selective price pass-through strategies and tiered product offerings. Some market leaders have introduced value lines with simplified formulations to preserve accessibility, while premium brands leverage proprietary delivery technologies to justify higher price points. In parallel, collaboration with contract manufacturers and co-packing partners has become more prevalent, distributing tariff-related risks and preserving supply continuity. Despite these headwinds, companies that strategically manage trade exposures and optimize supply chains can sustain growth.

Key Segmentation Insights Shaping Market Strategies

In-depth analysis of market segments reveals nuanced opportunities across six dimensions. By product type, consumer demand centers on capsules and tablets, with gelatin capsules maintaining dominance among traditional formulations while vegan capsules resonate with plant-based lifestyles. Liquid solutions present syrups and tinctures that enable rapid absorption and flexible dosing for diverse age groups. Powder variants in both flavored and unflavored options serve users seeking customizable mixing, whereas chewable and sublingual tablets offer on-the-go and mucosal delivery advantages.

Ingredient segmentation underscores the integration of amino acid modules, herbal extracts, prebiotic fibers, and probiotic strains alongside antibiotic components. Formulations pairing L-Glutamine or L-Tryptophan with targeted antibiotics support gut barrier integrity and neurochemical balance. Echinacea and Ginseng botanical extracts combine with antimicrobial agents to bolster immune resilience. Fructooligosaccharides and inulin prebiotics facilitate the growth of beneficial flora disrupted by antibiotics, while Bifidobacterium and Lactobacillus probiotics help reestablish microbial equilibrium.

Intended-use segmentation targets specific health objectives: anti-inflammatory blends address joint health and skin wellness through antibiotic-analog pathways; cognitive health products emphasize focus, attention, and memory enhancement; digestive health variants focus on bloating relief and gut flora balance; and immune support formulations integrate cold and flu prevention with general immune activation.

Distribution channels range from specialized health stores, including independent shops and specialty chains, to online retail platforms spanning direct manufacturer sites and e-commerce websites, as well as pharmacies-both chain and independent-and supermarkets that encompass convenience outlets and hypermarkets. Consumer demographic segmentation distinguishes usage patterns among adult, senior, and teenage populations, female and male cohorts, and lifestyle groups such as athletes, general population users, and health enthusiasts. Formulation innovation segmentation captures advanced delivery systems like liposomal and microencapsulation technologies, chemical-free preservative approaches with herbal and sugar-free solutions, and time-release matrices offering immediate or sustained antibiotic release.

Regional Market Dynamics: Americas, EMEA & Asia-Pacific Differences

In the Americas, demand reflects strong consumer awareness of microbiome science and robust retail networks spanning natural food chains, online direct channels, and pharmacy compounding services. Regulatory frameworks in the United States and Canada emphasize post-market safety and transparent labeling, fostering consumer trust. In the Europe, Middle East & Africa region, evolving regulations across the EU drive harmonization of antibiotic inclusion thresholds, while markets in the GCC and South Africa prioritize localized manufacturing and halal compliance. European consumers favor clean-label formulations and evidence-backed functional claims.

Asia-Pacific stands as a dynamic growth engine, with markets like China, Australia, Japan, and India exhibiting diverse regulatory environments and consumer preferences. Traditional medicine principles in China and India intersect with modern biosupplement approaches, creating hybrid formulations that leverage antibiotic analogs alongside herbal tonics. Rapid expansion of e-commerce platforms and mobile health applications accelerates adoption in urban centers, while rural markets benefit from simplified distribution via supermarkets and regional pharmacies. As these regional dynamics illustrate, tailored strategies that account for local regulations, cultural nuances, and distribution ecosystems are essential to unlocking growth potential.

Competitive Landscape: Leading Biosupplement Manufacturers and Innovators

As the competitive landscape intensifies, leading organizations differentiate through proprietary antibiotic formulations, integrated research partnerships, and diversified channel strategies. Abbott Nutrition leverages its global R&D capabilities to optimize antibiotic-biosupplement synergies, while BioGaia AB focuses on strain-specific probiotic-antibiotic combinations to address gut health. Biotics Research Corporation and Integrative Therapeutics, LLC emphasize practitioner-led distribution, reinforcing clinical credibility. Garden of Life LLC and Nature's Way Products, LLC capitalize on organic certifications and broad retail footprints, deploying antibiotic-enhanced blends that align with clean-label trends.

GenoVive Labs and Thorne Research, Inc. invest heavily in advanced delivery technologies such as microencapsulation and liposomal systems to improve antibiotic stability and absorption. MegaFood, Inc. and Sundown Naturals differentiate through non-GMO and vegan-friendly antibiotic formulations tailored to health-conscious consumers. Herbalife Nutrition Ltd. and LifeVantage Corporation utilize direct-selling models to foster community engagement and personalized product education. Royal DSM N.V. and NutraBio Labs, Inc. expand their ingredient portfolios by partnering with contract manufacturers to scale antibiotic precursors. Nordic Naturals and VitaBalance Inc. emphasize sustainability, integrating eco-friendly sourcing with antibiotic module innovation. Across the spectrum, companies that align antibiotic efficacy with functional health claims and seamless consumer experiences are poised to lead market growth.

Actionable Recommendations for Industry Leaders

To capitalize on emerging opportunities, industry leaders should accelerate investment in targeted antibiotic research and development, prioritizing narrow-spectrum compounds that preserve beneficial microbiota and align with resistance management guidelines. Companies must implement robust supply chain risk assessments to mitigate tariff impacts, exploring nearshore manufacturing hubs and strategic partnerships for ingredient sourcing. Embrace advanced delivery systems, including liposomal and microencapsulation technologies, to enhance antibiotic bioavailability and differentiate product portfolios. Strengthen compliance infrastructures by adopting real-time trade monitoring tools and harmonizing labeling practices across jurisdictions.

Tailor marketing strategies to region-specific regulations and consumer preferences, leveraging digital platforms for personalized outreach and subscription-based models. Collaborate with academic and clinical institutions to generate high-quality efficacy data, reinforcing professional endorsements and consumer trust. Finally, integrate sustainability metrics into antibiotic sourcing and packaging decisions, communicating environmental stewardship as a core brand value.

Conclusion and Strategic Imperatives

In summary, the biosupplements containing antibiotics category stands at the intersection of microbiome science, formulation innovation, and regulatory evolution. Companies that navigate tariff challenges, harness advanced delivery mechanisms, and tailor offerings to distinct market segments and regions will secure competitive advantage. Cultivating scientific partnerships and transparent communication will further reinforce credibility, while sustainability and personalized wellness strategies will drive consumer loyalty. As the landscape continues to evolve, proactive adaptation and strategic foresight will be essential for sustained growth and leadership.

Market Segmentation & Coverage

This research report categorizes the Biosupplements Containing Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Capsules
    • Gelatin Capsules
    • Vegan Capsules
  • Liquid Solutions
    • Syrups
    • Tinctures
  • Powders
    • Flavored Powders
    • Unflavored Powders
  • Tablets
    • Chewable Tablets
    • Sublingual Tablets
  • Amino Acids
    • L-Glutamine
    • L-Tryptophan
  • Herbal Extracts
    • Echinacea
    • Ginseng
  • Prebiotics
    • Fructooligosaccharides
    • Inulin
  • Probiotics
    • Bifidobacterium
    • Lactobacillus
  • Anti-Inflammatory
    • Joint Health
    • Skin Health
  • Cognitive Health
    • Focus & Attention
    • Memory Enhancement
  • Digestive Health
    • Bloating Relief
    • Gut Flora Balance
  • Immune Support
    • Cold & Flu Prevention
    • General Immune Boost
  • Health Stores
    • Independent Health Shops
    • Specialty Health Chains
  • Online Retail
    • Direct Manufacturer Sites
    • E-Commerce Websites
  • Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Supermarkets
    • Convenience Stores
    • Hypermarkets
  • Age Group
    • Adults
    • Seniors
    • Teenagers
  • Gender
    • Female
    • Male
  • Lifestyle
    • Athletes
    • General Population
    • Health Enthusiasts
  • Advanced Delivery Systems
    • Liposomal Delivery
    • Microencapsulation
  • Chemical-Free Preservatives
    • Herbal Preservatives
    • Sugar-Free Solutions
  • Time-Release Formulations
    • Immediate Release
    • Sustained Release

This research report categorizes the Biosupplements Containing Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biosupplements Containing Antibiotics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Nutrition
  • BioGaia AB
  • Biotics Research Corporation
  • Garden of Life LLC
  • GenoVive Labs
  • Herbalife Nutrition Ltd.
  • Integrative Therapeutics, LLC
  • LifeVantage Corporation
  • MegaFood, Inc.
  • Nature's Way Products, LLC
  • Nordic Naturals
  • NutraBio Labs, Inc.
  • Royal DSM N.V.
  • Sundown Naturals
  • Thorne Research, Inc.
  • VitaBalance Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biosupplements Containing Antibiotics Market, by Product Type
8.1. Introduction
8.2. Capsules
8.2.1. Gelatin Capsules
8.2.2. Vegan Capsules
8.3. Liquid Solutions
8.3.1. Syrups
8.3.2. Tinctures
8.4. Powders
8.4.1. Flavored Powders
8.4.2. Unflavored Powders
8.5. Tablets
8.5.1. Chewable Tablets
8.5.2. Sublingual Tablets
9. Biosupplements Containing Antibiotics Market, by Ingredients
9.1. Introduction
9.2. Amino Acids
9.2.1. L-Glutamine
9.2.2. L-Tryptophan
9.3. Herbal Extracts
9.3.1. Echinacea
9.3.2. Ginseng
9.4. Prebiotics
9.4.1. Fructooligosaccharides
9.4.2. Inulin
9.5. Probiotics
9.5.1. Bifidobacterium
9.5.2. Lactobacillus
10. Biosupplements Containing Antibiotics Market, by Intended Use
10.1. Introduction
10.2. Anti-Inflammatory
10.2.1. Joint Health
10.2.2. Skin Health
10.3. Cognitive Health
10.3.1. Focus & Attention
10.3.2. Memory Enhancement
10.4. Digestive Health
10.4.1. Bloating Relief
10.4.2. Gut Flora Balance
10.5. Immune Support
10.5.1. Cold & Flu Prevention
10.5.2. General Immune Boost
11. Biosupplements Containing Antibiotics Market, by Distribution Channel
11.1. Introduction
11.2. Health Stores
11.2.1. Independent Health Shops
11.2.2. Specialty Health Chains
11.3. Online Retail
11.3.1. Direct Manufacturer Sites
11.3.2. E-Commerce Websites
11.4. Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
11.5. Supermarkets
11.5.1. Convenience Stores
11.5.2. Hypermarkets
12. Biosupplements Containing Antibiotics Market, by Consumer Demographics
12.1. Introduction
12.2. Age Group
12.2.1. Adults
12.2.2. Seniors
12.2.3. Teenagers
12.3. Gender
12.3.1. Female
12.3.2. Male
12.4. Lifestyle
12.4.1. Athletes
12.4.2. General Population
12.4.3. Health Enthusiasts
13. Biosupplements Containing Antibiotics Market, by Formulation Innovation
13.1. Introduction
13.2. Advanced Delivery Systems
13.2.1. Liposomal Delivery
13.2.2. Microencapsulation
13.3. Chemical-Free Preservatives
13.3.1. Herbal Preservatives
13.3.2. Sugar-Free Solutions
13.4. Time-Release Formulations
13.4.1. Immediate Release
13.4.2. Sustained Release
14. Americas Biosupplements Containing Antibiotics Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Biosupplements Containing Antibiotics Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Biosupplements Containing Antibiotics Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Nutrition
17.3.2. BioGaia AB
17.3.3. Biotics Research Corporation
17.3.4. Garden of Life LLC
17.3.5. GenoVive Labs
17.3.6. Herbalife Nutrition Ltd.
17.3.7. Integrative Therapeutics, LLC
17.3.8. LifeVantage Corporation
17.3.9. MegaFood, Inc.
17.3.10. Nature's Way Products, LLC
17.3.11. Nordic Naturals
17.3.12. NutraBio Labs, Inc.
17.3.13. Royal DSM N.V.
17.3.14. Sundown Naturals
17.3.15. Thorne Research, Inc.
17.3.16. VitaBalance Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY VEGAN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TINCTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FLAVORED POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY UNFLAVORED POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUBLINGUAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY L-GLUTAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY L-TRYPTOPHAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ECHINACEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GINSENG, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SKIN HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FOCUS & ATTENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY MEMORY ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY BLOATING RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GUT FLORA BALANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COLD & FLU PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENERAL IMMUNE BOOST, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INDEPENDENT HEALTH SHOPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SPECIALTY HEALTH CHAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIRECT MANUFACTURER SITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ATHLETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENERAL POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH ENTHUSIASTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIPOSOMAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY MICROENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUGAR-FREE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 187. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 189. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 190. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 191. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 192. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 193. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 194. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 195. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 196. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 197. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 198. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 199. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 200. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 201. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 202. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 204. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 205. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 206. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 207. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 208. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 209. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 210. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 211. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 212. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 214. CANADA BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 215. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 217. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 219. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 221. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 222. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 223. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 224. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 225. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 226. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 227. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 228. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 229. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 230. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 232. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 233. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 235. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 236. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 238. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 239. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 240. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 241. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 242. MEXICO BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY IMMUNE SUPPORT, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HEALTH STORES, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY SUPERMARKETS, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 266. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 267. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY FORMULATION INNOVATION, 2018-2030 (USD MILLION)
TABLE 268. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ADVANCED DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CHEMICAL-FREE PRESERVATIVES, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TIME-RELEASE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY CAPSULES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INGREDIENTS, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY AMINO ACIDS, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY HERBAL EXTRACTS, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY INTENDED USE, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2018-2030 (USD MILLION)
TABLE 284. ASIA-PACIFIC BIOSUPPLEMENTS CONTAINING ANTIBIOTICS MARKET SIZE, BY COGNITIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 285. ASIA-PAC

Companies Mentioned

  • Abbott Nutrition
  • BioGaia AB
  • Biotics Research Corporation
  • Garden of Life LLC
  • GenoVive Labs
  • Herbalife Nutrition Ltd.
  • Integrative Therapeutics, LLC
  • LifeVantage Corporation
  • MegaFood, Inc.
  • Nature's Way Products, LLC
  • Nordic Naturals
  • NutraBio Labs, Inc.
  • Royal DSM N.V.
  • Sundown Naturals
  • Thorne Research, Inc.
  • VitaBalance Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Semi-synthetic ß-lactam Antibiotics Market - Global Forecast to 2030 - Product Image

Semi-synthetic ß-lactam Antibiotics Market - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Medicaments, Containing Antibiotics: World Trade, Markets and Competitors - Product Image

Medicaments, Containing Antibiotics: World Trade, Markets and Competitors

  • Report
  • 750 Pages
  • Global
From
Medicaments Containing Antibiotics, in the Form of Doses: World Trade, Markets and Competitors - Product Image

Medicaments Containing Antibiotics, in the Form of Doses: World Trade, Markets and Competitors

  • Report
  • 750 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.